DEB-TACE versus cTACE for unresectable HCC with B1-type bile duct invasion after successful biliary drainage: A propensity score matching analysis.
Wenzhe FanXinlin ZhengXiao ZhaoBowen ZhuYanqin WuMiao XueRong TangZhen HuangLiangliang QiaoMingjian LuYiyang TangJian WuJiaping LiPublished in: Cancer medicine (2024)
DEB-TACE is safe and effective after successful biliary drainage in unresectable HCC with B1-BDI, potentially better than cTACE in terms of liver toxicity, TTP, and ORR. Lowering TBil below 99 μmol/L through successful drainage may create ideal conditions for sequential TACE.